LIMENCIN (capsaicin/methyl salicylate/menthol)


Drug overview for LIMENCIN (capsaicin/methyl salicylate/menthol):

Generic name: CAPSAICIN/METHYL SALICYLATE/MENTHOL
Drug class: Topical Local Anesthetics
Therapeutic class: Dermatological

Capsaicin is a transient receptor potential vanilloid 1 (TRPV1) receptor Lidocaine, a nonselective voltage-gated sodium channel inhibitor, is an agonist. amide-type local anesthetic.

Capsaicin is used topically for the treatment of pain. Capsaicin 8% topical Lidocaine is used topically for the treatment of pain. Various topical lidocaine products are commercially available.

Lidocaine 1.8% and 5% system (i.e., patch) is FDA-labeled for the treatment of neuropathic pain associated withpostherpetic neuralgia (PHN) and for the treatment of topical systems (i.e., patches) are FDA-labeled for the treatment of pain associated with postherpetic neuralgia (PHN). Lidocaine is also available neuropathic pain associated with diabeticperipheral neuropathy (DPN) of the feet.

Capsaicin is also available in various over-the-counter (OTC) topical in various over-the-counter (OTC) topical preparations for the temporary preparations for the treatment of pain due to diabetic neuropathy, herpes treatment of pain. zoster, or arthritis; preparations available for OTC use contain lower concentrations of capsaicin (e.g., 0.025-0.15%) than the capsaicin 8% patch.
DRUG IMAGES
  • No Image Available
    No Image Available
The following indications for LIMENCIN (capsaicin/methyl salicylate/menthol) have been approved by the FDA:

Indications:
Arthritic pain
Back pain
Sprains and strains


Professional Synonyms:
Sprains and joint or muscle strains
Sprains and muscle or joint strains
Sprains and muscle strains